Mechanisms such as those described in prostate cancer, for example, the inhibition of cell proliferation, increased p21 expression with subsequent apoptosis and cell cycle arrest, may assign CD26 to be a suppressor in tumors (24). The gene discussed is DPP4; the disease is prostate carcinoma.